Basal-IQ Technology— 510(k) K193483
Substantially EquivalentTandem Diabetes Care, Inc.
FDA 510(k) clearance K193483 for Basal-IQ Technology, Substantially Equivalent on 2020-02-28. Applicant: Tandem Diabetes Care, Inc..
Clearance details
- Applicant
- Tandem Diabetes Care, Inc.
- Product code
- Code QJS
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- San Diego, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.